Literature DB >> 9444641

Orbital plasmacytoma in a cat.

D A Ward1, M F McEntee, D L Weddle.   

Abstract

An Abyssinian cat presented with epistaxis, melaena and retinal vascular changes. Plasma protein levels were markedly elevated and a monoclonal gammopathy was present on serum protein electrophoresis. Based on these laboratory findings, hyperviscosity syndrome was assumed to be responsible for the clinical signs. The cat responded initially to fluid therapy, but relapsed and then developed unilateral exophthalmia. The animal was euthanased and an extramedullary plasmacytoma of the right orbit was diagnosed at postmortem examination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444641     DOI: 10.1111/j.1748-5827.1997.tb03323.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  4 in total

1.  Diode laser coagulation for the treatment of epistaxis in a Scottish fold cat.

Authors:  Takuma Aoki; Hiroo Madarame; Keisuke Sugimoto; Hiroshi Sunahara; Yoko Fujii; Eiichi Kanai; Tetsuro Ito
Journal:  Can Vet J       Date:  2015-07       Impact factor: 1.008

2.  Primary orbital melanoma without ocular involvement in a Balinese cat.

Authors:  Louis-Philippe de Lorimier
Journal:  Can Vet J       Date:  2006-03       Impact factor: 1.008

3.  Primary duodenal plasmacytoma with associated primary (amyloid light-chain) amyloidosis in a cat.

Authors:  Yu Tamura; James K Chambers; Sakurako Neo; Yuko Goto-Koshino; Satoshi Takagi; Mizuho Uneyama; Kazuyuki Uchida; Masaharu Hisasue
Journal:  JFMS Open Rep       Date:  2020-09-21

4.  Myeloma-related disorders in cats commonly present as extramedullary neoplasms in contrast to myeloma in human patients: 24 cases with clinical follow-up.

Authors:  Paul J Mellor; Sean Haugland; Sue Murphy; Ken C Smith; Andrew Holloway; Joy Archer; Roger M Powell; Gerry A Polton; Severine Tasker; David McCormick; Michelle E Tempest; Pauline E McNeil; Timothy J Scase; Chris D Knott; Ugo Bonfanti; Elizabeth J Villiers; David J Argyle; Michael E Herrtage; Michael J Day
Journal:  J Vet Intern Med       Date:  2006 Nov-Dec       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.